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Introduction

Recombinant adenovirus vectors have been employed as gene transfer vehicles into human hematopoietic cells, including bone marrow-derived CD34
+ cells, [1] [2] [3] [4] and CD34 + cells derived from mobilized peripheral blood. 2 In comparison to retrovirus vectors, which so far have been the vehicles of choice for gene transduction into hematopoietic cells, 5 adenovirus vectors have potential advantages for clinical use: they infect cells in the quiescent phase of the cell cycle; 6 they transduce genes into an undifferentiated CD34 + CD38 − hematopoietic progenitor cell subset; 2 the expression level of the transgene is typically higher than that achieved with retrovirus vectors; 7 very high viral titers are achievable; and, most importantly, the modalities of target cell processing and viral transduction are not technically demanding, and feasible also in clinical situations that require transduction of large amounts of target cells (ie peripheral blood CD34 + cell transplantation). The major problem that obstructs widespread application of adenovirus vectors in hematopoietic cell gene transfer is the transitoriness of their expression (the viral genome does not integrate into host DNA). Furthermore, only a subset of CD34 + cells, as yet not characterized, is permissive for the infection. 2 Nevertheless, adenovirus vectors could potentially be utilized in gene therapy programs in which high expression of the transgene is required, and in which repeated reinfusions with gene-transduced cells would be feasible (ie immunotherapy, cancer drug resistance protocols).
So far, only a single report 2 has convincingly demonstrated that adenovirus vectors can efficiently transduce CD34 + hematopoietic progenitors derived from different sources. Since mobilized blood CD34
+ cells are now universally utilized as rescue in high-dose therapy programs, here we report a series of experiments aimed at evaluating the feasibility of gene transfer by adenovirus vectors into mobilized blood CD34 + cells. In particular, we: (1) confirm that mobilized blood-derived CD34 + cells from a homogeneous series of cancer patients can be efficiently transduced by adenovirus vectors; (2) test various modalities to improve gene transfer efficiency; (3) evaluate the persistence of adenovirus vector into the mobilized blood CD34 + cell progeny induced to differentiate along the myeloid and the dendritic cell lineage.
Results
Effect of multiplicity of infection on transfer rate CD34 + cells were immunoselected at a mean 82.5% purity (range 68-94%) from mobilized peripheral blood of cancer patients undergoing high-dose cyclophosphamide and filgrastim therapy, and infected with Ad-MFG-AP recombinant adenovirus vector at different MOI. Cells were infected with 100:1 and 500:1 MOI, and 48 h later were analyzed for surface expression of alkaline phosphatase (AP). In this particular experiment, cells became 18% and 29% AP-positive, respectively (Figure 1) , without appreciable difference in cell viability. Thus, a 500:1 MOI was utilized in all subsequent infection experiments.
Upon infection with Ad-MFG-AP vector, the mean percentage of CD34
+ cells that became AP-positive in 10 experiments was 40% (range 26-60%). These percentages are in agreement with those previously reported. 2 Fluorescence intensity of AP-positive cells was high, in the 10 2 -10 3 range, up to 2 logs over negative controls. 
Modification of culture conditions to improve transfer rate
Preincubation with hematopoietic growth factors: In an attempt to increase internalization of adenovirus into target cells by up-regulation of ␣v␤3 and ␣v␤5 integrin expression, we cultured CD34
+ cells for 72 h with GM-CSF and/or M-CSF, alone or combined with other cytokines, and infected them with Ad-MFG-AP vector at the end of the incubation period. The expression of ␣v␤3 and ␣v␤5 integrins was virtually absent on CD34 + cells after immunoselection (0.11% and 0.5%, respectively), and increased considerably after the 72-h incubation with cytokines (up to 40% CD34 + cells expressing either integrin, data not shown). After infection, no single cytokine or cytokine combination significantly increased AP expression compared to the 40% percentage reported above ( Figure 2 ).
Effect of different concentrations of serum, calcium and magnesium: We then investigated the influence of medium composition during infection, in particular the percentage of fetal calf serum (FCS) and the concentration of divalent ions calcium and magnesium in the medium. PBS was supplemented with FCS at 0, 5%, 10%, and 20% concentration, without appreciable differences in infection efficiency (data not shown). Calcium, as CaCl 2 -2H 2 O, was added to the PBS medium at 0, 0.9 and 1.8 mm, respectively; magnesium was employed as MgCl 2 -6H 2 O at 0, 0.5, and 1.0 mm, respectively. In all experiments, infection efficiency was not influenced by different concentrations of divalent ions (data not shown). Figure 3 ).
Reinfection
Persistence of transgene expression into CD34
+ cell progeny After adenovirus infection, CD34
+ cells were induced to differentiate into the myeloid and the dendritic lineages, and the persistence of the transgene into differentiated cells was studied by flow cytometry and by PCR. First, the whole CD34
+ cell population was cultured in complete medium with kit-ligand plus interleukin-3, and assayed for AP-positive cells at days +2, +12 and +22 of liquid culture. An AP + cell population was detectable by both flow cytometry and PCR at day 12. At day 22, AP + cells were not detectable by flow cytometry, and detectable by PCR only when the few residual AP + cells were enriched by immunoselection with the anti-alkaline phosphatase antibody 3F6 ( Figure 4) . CFU-GM colonies were grown from CD34 + cells after adenovirus infection, individually plucked after 12-14 days of culture, and analyzed for vector-specific sequences by PCR. Repeated experiments failed to show any PCR-positive colonies (data not shown). We reasoned that only a small minority of cells would have retained the adenovirus sequences, due to progressive dilution caused by cell division, and that those cells were below the limit of detection of PCR. To visualize those positive cells, the Ad-CMV-␤-gal adenovirus vector, carrying a ␤-galactosidase gene, was utilized to infect CD34 + cells. Colonies from infected cells were grown in 96-well plates, and cytochemically stained with X-gal. By this technique, approximately five cells in each colony were ␤-gal positive ( Figure 5 ).
In another set of experiments, CD34 + cells were infected with Ad-MFG-AP vector and induced to differentiate into dendritic cells, as previously described. 8 Cells were analyzed at different times after infection by dualcolor flow cytometry for simultaneous expression of AP and of CD1a, this latter as a marker of dendritic cell differentiation. Efficiency of transduction, as evaluated by AP expression, was 50% at day 5. By day 10, 12% of the entire cell population expressed the CD1a, and 11% of the cells were AP + . Double labelling with CD1a and AP
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Figure 2 Percentage of AP-positive CD34 + cells, infected by Ad-MFG-AP adenovirus vector following 72-h incubation with cytokine(s). Horizontal axis: AP-FITC fluorescence intensity; vertical axis: relative cell number; negative control: mock-infected CD34
+ cells.
showed that 2.9% of the entire cell population was both CD1a + and AP + . If we restrict the analysis only to CD1a + cells, the proportion of AP + cells was considerably higher (34%). By day 13, a sizeable proportion of cells (approximately 4%) still expressed the alkaline phosphatase; however, only 0.7% of the entire cell population was both CD1a
+ and AP + ( Figure 6 ).
Discussion
We confirm in this report that adenovirus vectors efficiently infect mobilized CD34 + cells, and that transduced sequences are retained and expressed by a small fraction of CD34 + cell progeny up to 22 days after infection.
The 40% transduction rate we have obtained, assessed by transgene expression, is in agreement with that observed by Neering et al 2 in bone marrow, cord blood, and mobilized blood CD34 + cells. Moreover, the fluorescence intensity of the transduced cell population is high, and maintained over several days in culture. This high expression rate associated with transduction by Ad-MFG-AP adenovirus vector of CD34 + progenitors is probably dependent on its MFG-s vector promoter, based on the Moloney leukemia virus, which is known to function efficiently in hematopoietic cells. 9 In contrast, we did not transcription is a key factor in adenovirus vectormediated transduction. Factors determining the susceptibility of the target CD34 + cells to the adenovirus infection are not entirely known. Adenovirus utilizes fiber protein to attach to a recently identified cell surface receptor, 11 and vitronectinbinding ␣v␤3 and ␣v␤5 integrins function as secondary receptors to mediate virus internalization. 12 The induction of integrin expression on the cell surface of human monocytes by exposure to granulocyte-macrophage colony-stimulating factor and to macrophage colony-stimulating factor promoted the binding of penton base protein, and facilitated adenovirus-mediated gene delivery. 13, 14 Based on these observations, we have evaluated integrin expression on CD34 + cell surface before and after incubation with cytokines, and attempted to relate integrin expression with transgene expression. We reasoned that the transgene expression should indirectly reflect the increase of adenovirus DNA translocation into the target cells. We observed that, before any cytokine manipulation, CD34
+ cells expressed very low amounts of integrins, yet a substantial fraction of CD34 + cells was permissive for adenovirus infection; moreover, treatment with hematopoietic growth factors effectively increased surface expression of integrins, but did not enhance expression of the transgene. Our results suggest that, as reported in other cell types, 15 integrin expression is not necessarily predictive of the extent of transgene expression in CD34 + cells. We also observed that reinfection of CD34 + cells that were AP-negative after the first round of adenovirus exposure resulted in an additional 16% infection rate, suggesting that the resistance to infection may be relative rather than absolute, and possibly related to the expression of the receptor during cell cycle phases or to other, not yet defined, conditions. Another mechanism that may be responsible for the increase of expression after the second round of infection, however, is induction of transcription by as yet unidentified factors, rather than 16 Several attempts to improve upon this infection efficiency by manipulating serum and divalent ion concentration achieved no increase in the transfer rate.
From a clinical point of view, in contrast with retrovirus vectors that require extensive culture of target cells and long incubation times, adenovirus vectors can infect mobilized blood CD34 + cells at extremely favorable conditions. According to our data, 500 million CD34 + cells, which would represent an optimal dose for the hematopoietic reconstitution of a cancer patient following myeloablative therapy, 17 could be efficiently infected by adenovirus vector at a 500:1 virus:target ratio with only 1.25 ml of supernatant, while 5 l of a retrovirus supernatant with a 10 6 p.f.u./ml titer would be needed for the same purpose. This dramatic simplification of infection conditions supports the utilization of adenovirus vectors for those clinical conditions in which permanent gene transfer into CD34
+ cells is not required. We can envisage two of these conditions, one being the autografting of CD34 + cells genetically modified by transduction of a cancer drug resistance gene(s), in which CD34
+ cells should express high levels of the drug-resistance gene just for the time period the drug is present in the plasma. However, immune response to adenoviral proteins, with subsequent elimination of transduced cells, could limit readministration of the vector-modified cells after an initial exposure. In this perspective, our strategy for induction of hematopoietic progenitor cell chemoprotection involves adenovirus transduction of a portion of mobilized CD34
+ cells to support short-term recovery after myeloablative chemotherapy, and simultaneous utilization of non-transduced cells for long-term hematopoietic reconstitution. The second circumstance in which adenovirus-mediated ex vivo transduction of CD34 + cells could be useful is the implementation of immunotherapy programs for cancer. We have demonstrated that antigenpresenting dendritic cells can be generated ex vivo from mobilized blood CD34 + cells, in large quantities and fully functional, ie capable of activating antigen-specific cytotoxic T lymphocytes. 8, 18 Adenovirus vectors could thus advantageously be utilized as a vehicle for delivering peptide tumor gene(s) into dendritic cells. We have shown that adenovirus transduction of CD34 + progenitors and subsequent differentiation into dendritic cells results in expression of the transgene in a small portion of mature (day 13) CD1a + dendritic cells. The rapid decrease of transgene expression in the progeny of adenovirus-transduced CD34 + cells may limit the efficiency of antigen presentation to cytotoxic T cells. Therefore, we are now studying the feasibility of transducing mature CD34-derived dendritic cells with adenovirus vector (M Di Nicola et al, submitted) .
In conclusion, mobilized blood CD34 + cells are able to be infected by adenovirus vectors in clinically acceptable conditions, and are potentially utilizable in clinical protocols of chemoprotection and immunotherapy.
Materials and methods
Target cells
Experiments were carried out on a fraction of blood cell transplant from patients treated with high-dose cyclophosphamide (HD-CTX; 7 g/m 2 ) cancer therapy plus recombinant human granulocyte colony-stimulating factor (rhG-CSF, filgrastim) for poor prognosis nonHodgkin's lymphoma, or operable breast cancer with у4 metastatic axillary nodes. Administration of filgrastim, 0.3 mg s.c. daily, was started on day +1 after HD-CTX. Clinical protocols were approved by INT-Milan Institutional Review Board and required written informed consent.
During hematopoietic recovery after pancytopenia induced by HD-CTX therapy, peripheral blood buffy coat cells were collected and cryopreserved to be used as the source of hematopoietic progenitor cells for autografting following subsequent myeloablative cancer therapy. Patients underwent peripheral blood leukapheresis employing the continuous flow blood cell apheresis system Cobe Spectra (Cobe BCT, Lakewood, CO, USA) with a previously described technique.
CD34
+ cells were selected by a previously described technique. 20 Briefly, leukapheresis cells were resuspended at a concentration of 333.3 x 10 6 cells/ml cells in PBS, with 0.5% autologous human serum, and 0.6% ACD (Baxter Healthcare, Thetford, UK) (PBE). One hundred microliters of blocking reagent and 100 l of the antibody reagent for 10 8 cells from the CD34 isolation kit (MiniMacs Miltenyi Biotec, Bergisch Gladbach, Germany), were added simultaneously to the cell suspension, mixed and allowed to incubate at 4°C for 15 min. After incubation, the cells were washed by adding 5 ml of PBE and centrifuging for 10 min at 800 g at 4°C. The supernatant was completely removed and the cell pellet carefully resuspended in cold PBE at a concentration of 250 x 10 6 cells/ml. One hundred microliters of colloidal suspension of submicroscopic magnetic beads for 10 8 cells was added to the cells, mixed and incubated at 4°C for 15 min, then washed with cold PBE. The separation columns were primed by washing with 1 ml of cold PBE and placed in a magnetic field. The washed cell pellet was carefully resuspended in PBE and applied to the prefilled column. Cells which did not bind CD34 antibody passed through the column while CD34 + cells were retained. The CD34 + cells were eluted by removing the column from the magnetic field and flushing the column with PBE. The entire procedure was performed according to the manufacturer's instructions.
K562 cell line was utilized as a positive control for the infection.
Adenovirus vectors
The Ad-MFG-AP vector has already been described. 2 Briefly, this recombinant adenovirus vector carries the human placental alkaline phosphatase gene engineered to retain the membrane-anchoring domain, so that the gene product is expressed on the cell surface and is detectable by flow cytometric analysis. Virus stock was assayed on the 293 cell line, and a functional titer of 2 × 10 11 p.f.u./ml was determined. The Ad-CMV-␤-gal adenovirus vector, carrying the ␤-galactosidase gene (␤-gal), was a generous gift from I Verma (The Salk Institute, San Diego, CA, USA). 21 Infection of target cells After immunoselection, 5 × 10 5 CD34 + cells were either resuspended in phosphate buffered saline with calcium and magnesium (PBS) supplemented with 5% FCS, or in Iscove's modified Dulbecco's medium (IMDM) at 1 × 10 6 cells/ml, and virus stock was added at 100-500:1 virus:target cell ratio for 1 h. Cells were then supplemented with 0.5 ml IMDM plus 20% fetal calf serum, kit ligand 100 ng/ml, and interleukin-3, 100 ng/ml, until further processing. In some experiments, CD34 + cells were cultured for 72 h before infection in IMDM-10% FCS plus the following hematopoietic growth factor(s), alone or in combination: kit ligand/stem cell factor (SCF), 50 ng/ml; FLT3/FLK2 (FLT3), 50 ng/ml; IL3, 50 ng/ml; GM-CSF, 50 ng/ml; M-CSF, 50 U/ml (see Results for details).
Flow cytometry assay After infection, CD34
+ cells were cultured for 48 h in IMDM/10% FCS plus kit ligand 50 ng/ml, and IL-3, 50 ng/ml. Infected cells were evaluated by dual-color flow cytometry with the anti-alkaline phosphatase antibody 3F6 (Serotec, Oxford, UK) plus fluoresceinated goat-antimouse antibody (Caltag, San Francisco, CA, USA) and with anti-CD34 HPCA-2 PE antibody (Becton Dickinson, San José, CA, USA). Isotype-matched irrelevant control antibody was utilized for FITC fluorescence. Alkaline phosphatase-positive cells were evaluated after appropriate gating of CD34 + cells.
Colony-forming unit (CFU-GM) assay CD34 + cells were cultured at a concentration of 1000-2000 cells per dish in duplicate in Methocult H4230 semisolid medium (Stem Cell Technologies, Vancouver BC, Canada) supplemented with 10% 5637 cell line conditioned medium. After 12-14 days in culture, single colonies were plucked by sterile pipette for PCR analysis.
In some experiments, CD34 + cells were resuspended in IMDM-10% FBS supplemented with GM-CSF 50 ng/ml, IL-3 50 ng/ml, SCF 50 ng/ml, and seeded in 60 roundbottom 96-well plates in 0.1 ml at a concentration of 100 cells/ml. After 14 days in culture, plates were centrifuged, and X-gal cytochemical staining of colonies for visualization of ␤-gal-positive cells was performed on colony-containing wells.
Generation of dendritic cells (DC) from mobilized CD34
+ cells
Immunomagnetically sorted CD34
+ cells were cultured in IMDM-10% FBS supplemented with GM-CSF 50 ng/ml, TNF-␣ 10 ng/ml, SCF 50 ng/ml, FLT3 50 ng/ml at 37°C in 5% CO 2 , as described. 8 The culture medium was replaced every 4-5 days; when the cells became confluent, the non-adherent fraction was cultured in additional dishes. The generation of DC was monitored at 4-5-day intervals by phase-contrast examination of intact cultures, and by direct immunofluorescence with phycoerythrin-conjugated CD1a and CD33 antibodies, and with fluorescein-conjugated CD14 antibody.
PCR analysis DNA was isolated from single colonies grown in semisolid medium by overnight incubation at 37°C in 50 l of buffer containing proteinase K (100 g/ml) and Tween 20 (final concentration 0.5%). After heat-inactivation of proteinase K at 95°C for 10 min, 25 l of each sample was subjected to PCR analysis with primers specific for the region of the Moloney murine leukemia retroviral vector. 22 PCR was performed for 35 cycles at 94°C for 1 min, 54°C for 1 min, and 72°C for 1 min. Amplification of infected cells by these primers resulted in a fragment of 423 bp, detected by 1.5% agarose gel electrophoresis and staining with ethidium-bromide. Quality control of DNA was performed using BCL-6 gene specific primers (forward primer 5′-ACGCTCTGCTTATGAGGA-3′, reverse primer 5′-CGGCAGCAACAGCAATAA-3′).
